Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Rang in aandelen #199
GSK plc, together with its subsidiaries, engages in the creation, discovery,... GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Aandeelprijs
$51.99
Marktkapitalisatie
$104.42B
Verandering (1 dag)
0.29%
Verandering (1 jaar)
32.49%
Land
GB
Handel GSK plc (GSK)

Categorie

Winst voor GSK plc (GSK)
Winst in Dec 2025 TTM: $9.95B
Volgens de meest recente financiële verslagen van GSK plc bedraagt de huidige winst van het bedrijf $9.95B. In 2024 behaalde het bedrijf een winst van $4.36B, een daling ten opzichte van de winst van 2023, die $7.72B bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van GSK plc van 2000 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $9.95B 2.24%
2025 $9.73B 123.11%
2024 $4.36B -43.48%
2023 $7.72B 13.38%
2022 $6.81B 39.93%
2021 $4.87B -31.16%
2020 $7.07B -14.32%
2019 $8.25B 34.93%
2018 $6.11B 28.34%
2017 $4.76B 99.06%
2016 $2.39B -84.57%
2015 $15.51B 235.45%
2014 $4.62B -58.00%
2013 $11.01B 2.83%
2012 $10.71B -10.38%
2011 $11.95B 143.12%
2010 $4.91B -61.53%
2009 $12.77B 31.37%
2008 $9.72B -35.26%
2007 $15.02B -1.77%
2006 $15.29B 31.99%
2005 $11.58B 4.33%
2004 $11.10B -1.73%
2003 $11.30B 27.36%
2002 $8.87B 0.26%
2001 $8.85B -1.72%
2000 $9.00B 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$25.73B 158.53%
US
$12.40B 24.61%
GB
$32.58B 227.36%
US
$6.60B -33.72%
US
$16.35B 64.30%
CH